In this issue briefing, the authors discuss how different strategies are needed to counter the burden of cardiovascular disease in Saudi Arabia. Large-scale public health interventions are at the cornerstone of this effort.
Reducing the Burden of Cardiovascular Disease in Saudi Arabia
Reducing the Burden of Cardiovascular Disease in Saudi Arabia
Health and Healthcare
$0.00
Heart attacks and strokes are common complications of cardiovascular disease (CVD). People with a history of CVD or who suffer from a genetic predisposition to high cholesterol levels are particularly vulnerable to heart attacks and strokes. By reaching World Health Organization risk factor reduction targets, Saudi Arabia could gain US$3.7 billion in health care cost and productivity savings between 2016 and 2035. Over the same time frame, Saudi Arabia could also save up to US$9.5 billion by helping high-risk groups lower their cholesterol levels.
Faced with rising health expenditures and an aging population, policy-makers need to act urgently. There is uncertainty, however, around which interventions may yield the biggest health and economic impacts. The current study, Reducing the Burden of Cardiovascular Disease in Saudi Arabia, fills some of this knowledge gap by assessing the impact of two very different, yet complementary, CVD reduction strategies.
Customers Who Downloaded This Also Liked
21 min read
40 min read
Require an accessible version of this research?
Upon request, Signal49 Research offers accessible versions of research. Please contact us to request your accessible version.
Learn more about our accessibility policies.
Effective January 26, 2026, AERIC Inc./Signal49 Research discontinued use of ‘The Conference Board of Canada’ name, logo and branding, which had been used by AERIC Inc./Signal49 Research under license from The Conference Board, Inc. The Conference Board, Inc. and its licensees, which are not affiliated with Signal49 Research, own all right, title and interest in THE CONFERENCE BOARD name and trademarks in Canada and have the exclusive right to their use in Canada since January 26, 2026.
